OMX30 1 585 0,1%  OMXH25 3 953 0,1%  OMXC20 1 020 0,4%  Dow 22 413 0,2%  Nas 5 974 -0,3%  EUR 9,5308 0,0%  USD 8,0272 0,1%  Olja 56,2 1,4%  Guld 1 299 -0,3% 

PAION Aktie

2,73EUR 0,04EUR 1,56%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för PAION

2016 2017e 2018e 2019e 2020e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal -5,81 -12,05 -35,80 63,11 -
Resultat/aktie -0,38 -0,23 -0,08 0,04 -

Nyheter om PAION AG

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om PAION AG

ytterligare analyser

PAION Peer Group

EVOTEC 18,65
-0,4%
Epigenomics 0,00
0,0%
MediGene 12,62
-1,8%
MorphoSys 68,60
0,0%
PAION 2,73
1,6%
Shire 38,05
-0,7%
pagehit

Lägg till instrument

Vad tycker du?

Profil PAION AGtill bolagsprofilen

PAION AG is a specialty pharmaceutical company developing and aiming to commercialize innovative drugs to be used in out-patient and hospital-based sedation, anesthesia and critical care services. PAION's lead compound is remimazolam, an intravenous, ultra-short-acting and controllable benzodiazepine sedative/anesthetic drug candidate, which is in Phase III clinical development for use in procedural sedation in the U.S. Currently, PAION is mainly focusing its business and financial resources on successfully completing its ongoing clinical development program in procedural sedation. Outside the U.S., PAION has so far focused on the development of remimazolam in the indication general anesthesia. A full clinical development program for general anesthesia was completed in Japan and PAION is preparing filing in Japan. In the EU, PAION is currently planning to continue the clinical development program. Development of remimazolam in the indication intensive care unit (ICU) sedation is also part of the longer-term life-cycle plan for remimazolam. The company was founded by Wolfgang Sohngen and Mariola Söhngen in January 2000 and is headquartered in Aachen, Germany.

Realtidskurs PAION AG

Bid 2,69 EUR Ask 2,71 EUR
Kurstid 20:24 Börsen STU

Aktiekurs PAION AG i EURPUSH CHART

Kurs 2,73 EUR 0,04 1,56 %
Kurstid 17:36:16
Datum 20.09.2017
Öppning 2,67
Gårdagen 2,69
Dagshögsta 2,73
Dagslägsta 2,65
52 v. högsta 3,53
52 v. lägsta 2,00
52 v. perf.
Volym (Antal) 84 742
Börsvärde (SEK) 1,56 Mrd
Börsen
Kurs för 2,73 EUR från börsen XETRA motsvarar med aktuell växelkurssentspricht EUR/SEK en kurs på 25,99 SEK.

Till aktien PAION

Ticker
ISIN DE000A0B65S3
Index Technology All Share, Prime All Share, CDAX

PAION Nyckeltal

Börsvärde i SEK 1,56 Mrd
Free float % 90,31
Antal aktier mio. 61,08
Cashflow/aktie i lokal valuta -0,21
Bokvärde/aktie i lokal valuta 0,47
60 dagar vola 38,53
PBV 4,70

PAION Historiska kurser

2017-09-20 2,73 84 742
2017-09-19 2,69 192 314
2017-09-18 2,76 80 209
2017-09-15 2,78 194 964
2017-09-14 2,81 52 229

Aktier i samma industri med bättre 1 års perf.

EVOTEC AG 297,7 %
Elanix Biotechnologies AG 167,7 %
co.don AG 163,6 %
Geneart AG 135,7 %
4SC AG 101,2 %